Your browser doesn't support javascript.
loading
Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.
Shah, Akshay; Chester-Jones, Mae; Dutton, Susan J; Marian, Ioana R; Barber, Vicki S; Griffith, David M; Singleton, Jo; Wray, Katherine; James, Tim; Drakesmith, Hal; Robbins, Peter A; Frise, Matthew C; Young, J Duncan; Walsh, Timothy S; McKechnie, Stuart R; Stanworth, Simon J.
Affiliation
  • Shah A; Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Adult Intensive Care Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: akshay.shah@linacre.ox.ac.uk.
  • Chester-Jones M; Oxford Clinical Trials Research Unit (OCTRU), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Dutton SJ; Oxford Clinical Trials Research Unit (OCTRU), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Marian IR; Oxford Clinical Trials Research Unit (OCTRU), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Barber VS; Oxford Clinical Trials Research Unit (OCTRU), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Griffith DM; Anaesthesia, Critical Care and Pain Medicine, University of Edinburgh, Edinburgh, UK; Deanery of Molecular, Genetic and Population Health Sciences and University of Edinburgh, Edinburgh, UK.
  • Singleton J; Anaesthesia, Critical Care and Pain Medicine, University of Edinburgh, Edinburgh, UK.
  • Wray K; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford, UK.
  • James T; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Drakesmith H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford, UK; Haematology Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Robbins PA; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
  • Frise MC; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK; Intensive Care Unit, Royal Berkshire Hospitals NHS Foundation Trust, Reading, UK.
  • Young JD; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Walsh TS; Anaesthesia, Critical Care and Pain Medicine, University of Edinburgh, Edinburgh, UK; Usher Institute for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
  • McKechnie SR; Adult Intensive Care Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Nuffield Department of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Stanworth SJ; Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Haematology Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Br J Anaesth ; 128(2): 272-282, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34872717
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferric Compounds / Hematinics / Anemia / Maltose Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Anaesth Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferric Compounds / Hematinics / Anemia / Maltose Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Anaesth Year: 2022 Type: Article